Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02429414 · ClinicalTrials.gov registry record · Phase 3
Video Double-Lumen Tube Prospective Randomized Study
A Phase 3 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 83
- Enrollment target
NCT02429414: Completed Phase 3 study, sponsored by M.D. Anderson Cancer Center.
NCT02429414 is a Phase 3 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02429414, a Phase 3 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 83 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn how often a fiberoptic bronchoscopy (FOB -- also known as a fiberoptic scope procedure) needs to be used with a video double lumen tube (VDLT) during surgeries that require lung isolation. On this study, you will have one of 2 types of commonly-used breathing tubes used, either a VDLT or a non-video double lumen tube (called a non-video DLT). An FOB may or may not be performed, as described below. The level of effectiveness of the VDLT and non-video DLT will be compared.
Interventions
- DEVICE Non-Video Double Lumen Tube (DLT)
- PROCEDURE Fiberoptic Bronchoscopy (FOB)
- DEVICE Video Double Lumen Tube (VDLT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-12-18 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02429414
The ClinicalTrials.gov registry entry for NCT02429414 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Non-Video Double Lumen Tube (DLT) is the first listed.
NCT02429414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02429414 about?
NCT02429414 is a clinical study titled "Video Double-Lumen Tube Prospective Randomized Study". The goal of this clinical research study is to learn how often a fiberoptic bronchoscopy (FOB -- also known as a fiberoptic scope procedure) needs to be used with a video double lumen tube (VDLT) during surgeries that require lung isolation. On this study, you will have one of 2 types of commonly-us...
What is the current status of trial NCT02429414?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 83 participants. The study started on 2015-09. Estimated completion is 2020-12-18.
What interventions are being tested in trial NCT02429414?
The interventions under investigation include: Non-Video Double Lumen Tube (DLT) (DEVICE), Fiberoptic Bronchoscopy (FOB) (PROCEDURE), Video Double Lumen Tube (VDLT) (DEVICE).
Who is sponsoring clinical trial NCT02429414?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.